Inactivation of TNF Signaling by Rationally Designed Dominant-Negative TNF VariantsPaul M. Steed, Bassil I. Dahiyat, Malú G. Tansey et al.|Science|2003Cited by 259
Dominant-Negative Inhibitors of Soluble TNF Attenuate Experimental Arthritis without Suppressing Innate Immunity to InfectionJonathan Zalevsky, David E. Szymkowski, Thomas Sécher et al.|The Journal of Immunology|2007Cited by 161
EVALUATION OF 250 FREE‐FLAP RECONSTRUCTIONS AFTER RESECTION OF TUMOURS OF THE HEAD AND NECKChristopher J. O’Brien, Koroush S. Haghighi, Harvey Stern et al.|Australian and New Zealand Journal of Surgery|1998Cited by 65
Accuracy of positron emission tomography in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancerRichard C. Martin, Christopher J. O’Brien, Michael Fulham et al.|Head & Neck|2008Cited by 34
CHANGING TRENDS IN THE MANAGEMENT OF CARCINOMA OF THE ORAL CAVITY AND OROPHARYNXChristopher J. O’Brien, KK Lee, W. J. S. Nettle|Australian and New Zealand Journal of Surgery|1993Cited by 20